Skip to main content
. 2017 May 30;114(27):7160–7165. doi: 10.1073/pnas.1705154114

Fig. 2.

Fig. 2.

Pharmacological validation of TMEM97 as the σ2 receptor. (A) PC-12 cells treated with Tmem97-targeted or control siRNA were tested to measure Tmem97 mRNA levels (Left) and σ2 expression by 3H DTG binding (Right). qPCR data are shown as mean ± SD. Radioligand binding data are shown as mean ± SEM and are representative of two independent experiments performed in triplicate. (B) 3H DTG saturation binding on Sf9 insect cell membranes expressing either TMEM97 (red circles) or the negative control β2 adrenergic receptor (blue squares). (C) 3H DTG competition curves in Sf9 insect cell membranes expressing TMEM97 against the known σ2 receptor ligands haloperidol (green circles), PB-28 (red squares), (+)-pentazocine (orange hexagons), (+)-SKF-10,047 (blue diamonds), SAS-1121 (purple triangles), and cold DTG (white triangles). (D) 3H DTG competition curves with the known TMEM97 ligands Elacridar (squares, dotted line) and Ro 48-8071 (circles, solid line) in Sf9 insect cell membranes expressing TMEM97 (red) and in MCF-7 cell membranes (blue). For all curves, data points are shown as mean ± SEM and are representative of two independent experiments performed in triplicate.